Title : The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2.

Pub. Date : 2012 Sep

PMID : 22778153






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2. ponatinib fms related receptor tyrosine kinase 3 Homo sapiens
2 Ponatinib is a novel tyrosine kinase inhibitor with potent activity against BCR-ABL with mutations, including T315I, and also against fms-like tyrosine kinase 3. ponatinib fms related receptor tyrosine kinase 3 Homo sapiens